Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 318
of 16Next
3:

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.

Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, Zentall SS, Arnold LE, Burgess JR.

Lipids. 2003 Oct;38(10):1007-21.

PMID: 14669965 [PubMed - indexed for MEDLINE]

4:

Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids.

Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelstein G, Bodennec J.

Am J Clin Nutr. 2008 May;87(5):1170-80.

PMID: 18469236 [PubMed - indexed for MEDLINE]

5:

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.

Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC.

J Pediatr. 2001 Aug;139(2):189-96.

PMID: 11487742 [PubMed - indexed for MEDLINE]

7:

Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD).

Germano M, Meleleo D, Montorfano G, Adorni L, Negroni M, Berra B, Rizzo AM.

Nutr Neurosci. 2007 Feb-Apr;10(1-2):1-9.

PMID: 17539477 [PubMed - indexed for MEDLINE]

9:

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study.

Hirayama S, Hamazaki T, Terasawa K.

Eur J Clin Nutr. 2004 Mar;58(3):467-73.

PMID: 14985685 [PubMed - indexed for MEDLINE]

10:

Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.

Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY.

Clin Chem. 2006 Dec;52(12):2265-72. Epub 2006 Oct 19.

PMID: 17053155 [PubMed - indexed for MEDLINE]

11:

Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.

Hogg RJ, Fitzgibbons L, Atkins C, Nardelli N, Bay RC; North American IgA Nephropathy Study Group.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1167-72. Epub 2006 Sep 27.

PMID: 17699343 [PubMed - indexed for MEDLINE]

12:

Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.

Buckley R, Shewring B, Turner R, Yaqoob P, Minihane AM.

Br J Nutr. 2004 Sep;92(3):477-83.

PMID: 15469651 [PubMed - indexed for MEDLINE]

13:

Differential effects of eicosapentaenoic and docosahexaenoic acids upon oxidant-stimulated release and uptake of arachidonic acid in human lymphoma U937 cells.

Obajimi O, Black KD, MacDonald DJ, Boyle RM, Glen I, Ross BM.

Pharmacol Res. 2005 Aug;52(2):183-91.

PMID: 15967385 [PubMed - indexed for MEDLINE]

15:

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID: 17692731 [PubMed - indexed for MEDLINE]

16:

Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.

Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S, Tanouchi M, Watanabe S, Hamazaki T, Terasawa K, Yazawa K.

Nutrition. 2005 Jun;21(6):705-10.

PMID: 15925295 [PubMed - indexed for MEDLINE]

17:

No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.

Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA, Ness AR.

Br J Nutr. 2008 Feb;99(2):421-31. Epub 2007 Oct 24.

PMID: 17956647 [PubMed - indexed for MEDLINE]

18:

A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.

Kratochvil CJ, Vaughan BS, Mayfield-Jorgensen ML, March JS, Kollins SH, Murray DW, Ravi H, Greenhill LL, Kotler LA, Paykina N, Biggins P, Stoner J.

J Child Adolesc Psychopharmacol. 2007 Apr;17(2):175-85.

PMID: 17489712 [PubMed - indexed for MEDLINE]

19:

Dietary effects of eicosapentaenoic and docosahexaenoic acid esters on lipid metabolism and immune parameters in Sprague-Dawley rats.

Hung P, Gu JY, Kaku S, Yunoki S, Ohkura K, Ikeda I, Tachibana H, Sugano M, Yazawa K, Yamada K.

Biosci Biotechnol Biochem. 2000 Dec;64(12):2588-93.

PMID: 11210121 [PubMed - indexed for MEDLINE]

20:

Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD).

Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, Chaudhary A, Bhave S, Pandit A.

Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):17-21. Epub 2005 Nov 28.

PMID: 16314082 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 318
of 16Next